Last updated on September 2018

A Safety and Tolerability Study of an Investigational Drug ALN-TTRSC02 in Healthy Subjects


Brief description of study

The purpose of this study is to determine the safety, tolerability, pharmacokinetics and pharmacodynamics of ALN-TTRSC02 in healthy subjects.

Clinical Study Identifier: NCT02797847

Contact Investigators or Research Sites near you

Start Over

Clinical Trial Site
London, United Kingdom

Recruitment Status: Closed


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.